Business Standard MNCs, Indian drugmakers diverge to mutual gain: How win-win is it?
Novartis exits India's mass-market generics, signalling a deeper split between MNC innovation bets and domestic pharma scale
Novartis exits India's mass-market generics, signalling a deeper split between MNC innovation bets and domestic pharma scale